Philipj Dolan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Philipj dolan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Philipj Dolan Today - Breaking & Trending Today

Prothena Corporation plc: Prothena Announces Promising New Preclinical and Clinical Data from its Neurodegenerative Programs Selected for Oral Presentations at AD/PD 2021


(2)
Robust preclinical data support the benefit of PRX005, a novel anti-tau antibody, for the potential treatment Alzheimer s disease
New pre-specified exploratory subgroup analyses and new digital biomarker data from Part 1 of the Phase 2 PASADENA study of prasinezumab in patients with early Parkinson s disease
will be featured in two separate presentations
DUBLIN, Ireland, Feb. 24, 2021 (GLOBE NEWSWIRE) Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid and neurodegenerative diseases, today announced three oral presentations and participation in a live forum at The 15
th International Conference on Alzheimer s and Parkinson s Diseases (AD/PD 2021). Prothena will present new preclinical data demonstrating that targeting a novel epitope with PRX005, an anti-tau antibody, resulted in superior attributes for the potential trea ....

Gennaro Pagano , Ellen Rose , Jennifer Zibuda , Kirsteni Taylor , Philipj Dolan , Wagner Zago , Head Of Communications , Investor Relations Communications , International Conference On Alzheimer , Company On Twitter Prothenacorp , Exchange Commission , Protein Sciences , Roche Pharma Research , Translational Technology , Early Development , Group Leader , Bristol Myers Squibb , Prothena Corporation , International Conference , Bristol Myers , Chief Scientific , Microtubule Binding Region , Bispecific Antibody , Pathological Tau Progression Via Blockade , Tau Pathology , Therapeutic Strategies ,